April 19, 2026 - 11:31

For more than four decades, Aviv Carmel has been a foundational force in Israel's construction landscape, fundamentally shaping the nation's tower crane industry. His career is distinguished by a rare fusion of forward-thinking vision, hands-on practical ingenuity, and profound, hard-won experience in the field.
Carmel’s journey began on the ground, operating cranes and intimately learning their mechanics and capabilities. This practical foundation fueled his innovative spirit, leading him to pioneer new methodologies and safety protocols that have become standard practice. His deep understanding of both the machines and the demands of complex construction sites allowed him to develop solutions that were not only technologically sound but also immensely practical for everyday use.
As a leader, his influence extends beyond machinery to the cultivation of skilled professionals and the elevation of industry standards. He is widely regarded as a mentor and a pivotal figure whose contributions have directly enabled the rise of Israel's modern skyline. Through a steadfast commitment to innovation and excellence, Aviv Carmel’s legacy is permanently etched into the steel and concrete of the nation's urban fabric.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...